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Summary 
 
Transient receptor potential channel type 6 (TRPV6) and Calbindin-D9k (CaBP-9k) 
are involved in the active calcium (Ca2+) transport mechanism in many tissues 
including placenta and uterus, suggesting a role in the establishment and maintenance 
of pregnancy. Moreover, TRPV6 and CaBP-9k seem to support the materno-fetal 
Ca2+ transport that is crucial for fetal Ca2+ homeostasis, bone growth and 
development. However, it is unknown if these proteins are also involved in the 
aetiology of pathologies associated with parturition in cows, such as retained fetal 
membranes (RFM). The aim of the current study was to create an expression profile 
of uterine and placentomal TRPV6 and CaBP-9k mRNAs and proteins during 
pregnancy and postpartum in cows that discharged the fetal membranes in comparison 
to cows that retained them. 
The results of the present study demonstrate a dynamic expression of TRPV6 and 
CaBP-9k during pregnancy in the bovine uterine endometrium and placentomes, 
suggesting a functional role for these proteins in Ca2+ metabolism during pregnancy. 
The temporal and spatial expression patterns indicate that TRPV6 and CaBP-9k may 
be involved in materno-fetal Ca2+ transport, mainly through an interplacentomal 
transport, and that both proteins may participate in physiological processes that are 
crucial for fetal and placental development. However, neither TRPV6 nor CaBP-9k 
seem to be causative in the retention of fetal membranes. 
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Zusammenfassung 
 
Transient receptor potential channel type 6 (TRPV6) und Calbindin-D9k (CaBP-9k) 
sind wichtige Elemente des aktiven Calcium (Ca2+) Transport in vielen Geweben und 
scheinen an der Etablierung und Aufrechterhaltung der Trächtigkeit beteiligt zu sein.  
Im Uterus sind TRPV6 und CaBP-9k als wichtige Faktoren für die myometriale 
Kontraktilität und Sekretion von Matrixkomponenten beschrieben. In der Plazenta 
scheinen beide Proteine am materno-fetalen Ca2+ Transport beteiligt zu sein. Ob 
TRPV6 und CaBP-9k ein Rolle in der Entstehung von Geburtspathologien spielen ist 
unbekannt.  
Das Ziel dieser Studie ist ein Expressionsprofil von uterinem und plazentärem TRPV6 
und CaBP-9k Protein und mRNA während der Trächtigkeit des Rindes zu erstellen 
sowie die plazentäre Expression von Tieren mit Nachgeburtsverhaltung (NGV) der 
von Tieren mit physiologischer Nachgeburtsablösung gegenüberzustellen. 
Die Ergebnisse dieser Studie demonstrieren eine zeitlich dynamische Expression von 
TRPV6 und CaBP-9k in Uterus, Plazenta und fetalen Membranen und lassen einen 
Einfluss beider Proteine auf den Verlauf und Erhalt der Trächtigkeit des Rindes 
vermuten. Die Lokalisation sowie das zeitliche Expressionsmuster deuten auf eine 
Rolle beider Proteine am interplazentären materno-fetalen Ca2+-Transport hin. Zudem 
scheinen beide Proteine einen Einfluss auf die fetale und plazentäre Entwicklung zu 
haben. Dennoch scheinen weder TRPV6 noch CaBP-9k eine Rolle bei der Entstehung 
von NGV zu spielen. 
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Abstract 
 
Background 
Transient receptor potential channel type 6 (TRPV6) and Calbindin-D9k (CaBP-9k) 
are involved in the active calcium (Ca2+) transport mechanism in many tissues 
including placenta and uterus, suggesting a role in the establishment and maintenance 
of pregnancy. Moreover, TRPV6 and CaBP-9k seem to support the materno-fetal 
Ca2+ transport that is crucial for fetal Ca2+ homeostasis, bone growth and 
development. However, it is unknown if these proteins are also involved in the 
aetiology of pathologies associated with parturition in cows, such as retained fetal 
membranes (RFM). The aim of the current study was to create an expression profile 
of uterine and placentomal TRPV6 and CaBP-9k mRNAs and proteins during 
pregnancy and postpartum in cows with and without fetal membrane release. 
 
Methods 
Uteri and placentomes of 27 cows in different stages of pregnancy and placentomes of 
cows with and without RFM were collected. Protein and mRNA expression of 
TRPV6 and CaBP-9k was investigated by real-time PCR, immunohistochemistry and 
Western blot. 
 
Results 
In the uterine endometrium, highest TRPV6 and CaBP-9k expression was found in 
the last trimester of pregnancy, with a particular increase of protein in the glandular 
epithelium. In the placentomes, a gradual increase in TRPV6 mRNA was detectable 
towards parturition, while protein expression did not change significantly. 
Placentomal CaBP-9k expression did not change significantly throughout pregnancy 
but immunohistochemistry revealed an increase in staining intensity in the maternal 
crypt epithelium. Immunohistochemically, stronger placental CaBP-9k signals were 
seen in animals with RFM compared to animals with an undisturbed fetal membrane 
release, while protein levels, measured by Western blot analyses did not change 
significantly. 
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Conclusion 
The results of the present study demonstrate a dynamic expression of TRPV6 and 
CaBP-9k during pregnancy in the bovine uterine endometrium and placentomes, 
suggesting a functional role for these proteins in Ca2+ metabolism during pregnancy. 
The temporal and spatial expression patterns indicate that TRPV6 and CaBP-9k may 
be involved in materno-fetal Ca2+ transport, mainly through an interplacentomal 
transport, and that both proteins may participate in physiological processes that are 
crucial for fetal and placental development. However, neither TRPV6 nor CaBP-9k 
seem to be causative in the retention of fetal membranes. 
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Background 
 
The presence of Ca2+ in female reproductive tissues is essential during pregnancy. 
Uterine Ca2+ ions are thought to be involved in the establishment and maintenance of 
pregnancy, possibly by controlling myometrial activity and by influencing the 
secretion of extra-cellular matrix components [1-3]. Furthermore, materno-fetal 
transport of Ca2+ is crucial for fetal development, e.g. bone mineralization, 
neuromuscular activities, and blood coagulation [4, 5]. In the placenta, Ca2+ functions 
as an important second messenger that regulates several cellular processes such as 
transcription, proliferation, differentiation, necrosis and apoptosis [6]. During 
pregnancy, the fetal requirement for Ca2+ increases strikingly, especially in the last 
trimester of gestation: the Ca2+ content of bovine fetuses increased from 3g/kg at d 
100 postmating to 8g/kg at d 280, indicating a high level of materno-fetal Ca2+ 
transfer [7]. This Ca2+ must be transported against a concentration gradient from the 
mother to the fetus [8], thus an active transport mechanism is required.  
TRPV6 and CaBP-9k (also known as S100 calcium binding protein G) are crucial 
elements in the active transport mechanism of mammals. TRPV6 is an epithelial Ca2+ 
channel, localised in the apical membrane of epithelial cells in several tissues, 
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including small intestine, kidney, uterus and placenta [9], which mediates Ca2+  uptake 
into the cell. CaBP-9k is known to facilitate intracellular Ca2+ transport from the 
apical to the basolateral cell membrane and functions additionally as an intracellular 
buffer of Ca2+ in many tissues, such as intestine, bone, uterus and placenta [10]. The 
expression, and to a certain extent, the regulation of CaBP-9k and TRPV6 in female 
reproductive tissues is well documented in several mammalian species, such as rat, 
mouse, pig and human [5, 11-14]. Unlike in Ca2+-absorbing organs like the 
duodenum, where the expression of these proteins is regulated mainly via vitamin-D, 
their expression in the female reproductive system seems to be regulated via the 
steroid hormones progesterone and estrogens [2, 11, 12]. Interestingly, there are 
distinct variations in the expression and regulation of both proteins among different 
mammals, which explains their species-specific, dynamic expression patterns during 
the estrous cycle and pregnancy [1, 2, 11].  
The clinical importance of TRPV6 in female reproductive tissues has been shown 
using TRPV6-knockout mice [4].  These animals showed reduced fertility, the 
materno-fetal Ca2+ transport was 40% lower and fetal Ca2+ accumulation was reduced 
compared to wildtype mice. The physiological role of uterine CaBP-9k appears to be 
the regulation of myometrial activity, while in the placenta CaBP-9k is thought to be 
involved in the regulation of the materno-fetal Ca2+ transport [3, 12].  
Taken together, several findings indicate that TRPV6 and CaBP-9k may play an 
important role in the establishment and maintenance of pregnancy and the materno-
fetal Ca2+ transport in mammals. Thus an undisturbed Ca2+ metabolism in the 
reproductive tissues is crucial for fertility and fetal health.  
So far, however, the expression of uterine and placentomal TRPV6 expression has not 
been studied during pregnancy in the cow. Moreover, it is unknown if TRPV6 or 
CaBP-9k are involved in the development of pathologies related to pregnancy and 
parturition. The expression of bovine CaBP-9k was investigated in the bovine uterus 
during the estrous cycle [15], where it was mainly detected during the luteal phase, 
and placentomal CaBP-9k was examined in the second half of pregnancy, where its 
expression level increased during the last trimester, correlating with the increased 
fetal Ca2+ demand [16].  
This study was performed to obtain further information about the uterine and 
placentomal Ca2+ metabolism at different stages of pregnancy in the cow. Therefore, 
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the temporal and spatial expression patterns of TRPV6 and CaBP-9k protein and 
mRNA in the uterine endometrium and in the placentomes were examined. 
Retained fetal membranes (RFM) in cows are described as an anomaly in the normal 
release of the fetal membranes within 12 hours after calving [17]. The mechanism 
leading to RFM is still unclear. Factors such as nutritional deficiencies, inflammation 
of the placenta after parturition, disturbances in maturation of the fetomaternal unit 
and in apoptotic processes have all been implicated in the aetiology of RFM [18]. 
Since Ca2+ plays such an important role in many cellular processes concerning 
placental maturation, such as proliferation, differentiation, transcription or apoptosis 
[6], it is also a matter of interest if TRPV6 and CaBP-9k may be involved in the 
detachment of the placenta postpartum. Therefore, this study further investigated the 
placental expression of TRPV6 and CaBP-9k postpartum in animals that discharged 
their fetal membranes within 12 hours after parturition and animals that did not.  
 
Methods 
 
Animals  
Uteri of 45 pregnant Holstein-Friesian cows were collected at the local abattoir and 
three or four at each month 2-9 of gestation were selected at random for the present 
study. Within 30 minutes after the animals were killed, they were eviscerated, the 
pregnant uteri were opened and the crown-rump lengths of the 45 fetuses were 
recorded to estimate fetal age as described by Boos et al. [19]. 
The study also examined placental specimens of five spontaneously calving 
postpartum cows that discharged the fetal membranes (DFM) within 12 hours after 
expulsion of the fetuses and of five animals that retained fetal membranes (RFM). 
These cattle were members of the university dairy herd or patients from the Clinic for 
Bovine Obstetrics and Gynaecology, University of Veterinary Medicine Hannover, 
Foundation.  
Animal experiments were approved by the administration of the district Hannover, 
and performed according to the German Law for the Protection of Animals 
(TierschG) and the recommendations of the German Society of Laboratory Animal 
Science (GV-SOLAS). 
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Tissue sampling and Processing 
At the abattoir, at least two randomly selected and comparatively large placentomes 
and two segments of the interplacentomal uterine wall including adherent 
allantochorion were excised from each animal. Macroscopically visible caruncles, the 
adhering allantochorion and the surrounding segment of the uterine wall were excised 
from the uterine horn ipsilateral to the corpus luteum in early pregnant cows. Only a 
single placentome each -but no uterine wall- was collected from ten cows within one 
hour after the expulsion of their calf. For excision of placentomes from live cows, an 
elongated effeminator according to Reisinger (1906), modified by Richter (1936) 
(Hauptner, Solingen) was used. 
A centrally located cross section of approximately 10 mm in thickness was performed 
on selected placentomes. The sections were cut in pieces of 10x10mm and three 
samples each were selected for further processing. These were: (1) uterine wall 
oriented – concave side – tissue cube, i.e., placental tissue including maternal plate 
and placental stalk material; (2) allantoic sac oriented – convex side – tissue cube, i.e., 
placental tissue including fetal plate material, and finally (3) tissue cube collected 
from the periphery – equatorial – also including fetal plate and placental tissue. The 
specimens were oriented and mounted in Tissue-Tek II® (Miles, Elkhart, Ind., USA) 
on cork lamellae, snap frozen and stored at -80°C. 
For immunohistochemistry, tissue samples were rinsed in 0.9% saline, fixed in 4% 
neutral buffered formalin for 24 hours and finally embedded in paraffin (Histowax, 
Leica) as previously described [19]. 
 
RNA isolation and quantitative Real-Time (TaqMan) PCR 
Total RNA from bovine uterine wall and placentomes from the 2nd to 9th month of 
pregnancy (n=3 animals /month) and placentomes of postpartum cows with (RFM, 
n=5) and without retained fetal membranes (DFM, n=6) was isolated using TRIzol 
Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. RNA 
concentration was measured by spectrophotometry (SmartSpecTM Plus 
Spectrophotometer, Biorad, Reinach, Switzerland). Purity and quality of mRNA were 
determined by optical density (OD) measurement. The OD 260/280 ratio of all 
samples was greater than 1.8. Then, 200 ng of total RNA was DNase treated (DNase I 
recombinant, RNase free, Roche Diagnostics, Indianapolis, USA) and reverse 
transcribed using the Gold RNA PCR Core Kit (Gene Amp, Applied Biosystems, 
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Foster City, CA). The RT reaction was run for 8 minutes at 21°C, 15 minutes at 45°C 
and 5 minutes at 99°C. 
Real Time (TaqMan) PCR was performed using the ABI 7500 Fast Real-Time PCR 
System (Applied Biosystems, Rotkreuz, Switzerland), as described previously [20]. In 
brief, samples were amplified in duplicates in a 25-µl reaction mixture containing  
12.5 µl FastStart Universal Probe Master (Roche Diagnostics, Mannheim, Germany), 
300 nM of each primer, 200 nM TaqMan probe and 5 µl cDNA. Autoclaved water 
instead of RNA and the so-called RT minus control were used as negative controls. 
Primers and 6-carboxyfluorescein (6-FAM)- and 6-carboxytetramethyl-rhodamine 
(TAMRA)-labelled probes were designed using Primer Express Software (Applied 
Biosystems) and ordered from Eurogentec, B-4102 Seraing, Belgium. For primer and 
probe sequences see Table 1. The expression levels of TRPV6 and CaBP-9k were 
quantified by the comparative CT method, calculated relative to the expression of the 
reference gene GAPDH and normalised to the calibrator. The sample with the lowest 
level of the respective target gene transcripts was used as the calibrator. The 
efficiency of the PCR reactions was verified using the CT slope method according to 
the instructions of the manufacturers of the ABI 7500 Fast Real-Time PCR System. 
The specificity of the selected PCR products was confirmed by sequencing 
(Microsynths, Switzerland). !
Immunohistochemical analysis 
Paraffin-embedded tissue samples were cut at 3µm. Sections were dewaxed using 
xylol and rehydrated through serial dilutions of ethanol to water and rinsed in water. 
Antigen retrieval was performed by boiling the sections in 10mM citrate buffer pH 
6.0 in a microwave oven (600 W, 3 x 5 minutes) and rinsing in Tris-buffered saline 
(TBS, buffer stock solution: 6.1 g Trizma base, 50 ml H20 and 37 ml 1 N HCl, diluted 
with H2O to 1000 ml solution, pH adjusted to 7.6; working solution: 100 ml buffer 
stock solution plus 900 ml 0.85% saline). Endogenous peroxidase activity was 
inhibited by incubating the sections in 0.3% H2O2 in methanol for 15 minutes. Non-
specific binding was blocked with 10% normal goat serum. The tissue sections were 
incubated at 4°C overnight with the primary antibody. The expression of TRPV6 was 
detected with a rabbit polyclonal anti-TRPV6 antibody (ACC-036, Alomone Labs, 
Israel) at a 1:200 dilution, which reacts with the intracellular C-terminus. The 
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expression of CaBP-9k was detected with a rabbit polyclonal anti-CaBP-9k-antibody 
(Swant, Bellinzona, Switzerland) at a dilution of 1:5000, which was produced against 
rat recombinant Calbindin-D9k protein. As negative controls, tissue sections were 
incubated with an isotype specific rabbit IgG (Vector Laboratories, Burlingame, CA, 
USA) and with TBS instead of the primary antibody.  
After rinsing in TBS for 3x10 minutes, the biotinylated secondary antibody 
(PowerVision Poly-HRP IHC Detection System, goat anti-Rabbit IgG) was added in 
dilution of 1:200 and sections were incubated for 30 minutes at 23°C. After washing 
in TBS for 2x10 minutes, the tissue sections were incubated for 30 minutes with 
StreptABComplex/HRP Duett (Dako, Glostrup, DK), and Chromogen 
diaminobenzidine tetrahydrochloride (Liquid DAB+ Substrate, Dako, Baar, 
Switzerland) was added. Before being automatically coverslipped (RCM 2000!; 
Medite) in Pertex® (Medite), the sections were counterstained with haematoxylin. 
 
Western blot 
The tissue samples (n=3 animals/month) were homogenised in NET-2 buffer (50 mM 
TRIS-HCl, pH 7.4, 300 mM NaCl, 0.05% Nonidet P-40 [21] containing 1 µl/ml 
protease inhibitor (Sigma-Aldrich, Buchs, Switzerland) and centrifuged (1000 g) for 
10 minutes at 4°C. The clarified supernatants were removed, and the protein 
concentrations were determined by the Bradford method (Bradford, 1976) (Bio-Rad 
Laboratories, Reinach, Switzerland). Samples were diluted with NET-2 buffer and 
sample buffer, containing "-mercaptoethanol, and incubated for 5 minutes at 95°C.  
Proteins were separated on SDS-Gel (TRPV6: 10% polyacrylamide, CaBP-9k: 12% 
polyacrylamide) and transferred onto PVDF membranes. For the deglycosylation of 
TRPV6, the proteins were denatured at 100°C and incubated with N-glycosidase F 
(PNGase F, New England Biolabs, Frankfurt, Germany) at 37° C for 1 hour, before 
separation by SDS-Gel, according to the manufacturer’s protocol. After blocking the 
membranes in 5% fat-free milk in PBS-T (Tris-buffered saline with 0.025% Tween-
20) for one hour, the membranes were incubated overnight at 4°C with the primary 
antibodies diluted in 2.5% milk/PBS-T. The antibodies were identical to those used 
for immunohistochemistry, diluted 1:500 (TRPV6) and 1:5000 (CaBP-9k). As a 
negative control for the TRPV6 antibody, samples were preincubated with a specific 
control antigen (Alomone labs, Israel). 
! "$!
Afterwards, the blots were washed in PBS-T three times for 10 minutes and incubated 
with the secondary peroxidase-conjugated antibody for one hour at 23°C (anti-rabbit 
IgG (H+L) HRP conjugate, Promega, Dübendorf, Switzerland). Membranes were 
washed five times in PBS-T for 10 minutes. Protein detection was performed by 
chemiluminescence (Immun-Star HRP Substrate Kit, Bio-Rad) and exposed to LAS-
3000 (Fujifilm). The membranes were reblotted with anti-GAPDH antibody at a 
1:5000 dilution as the loading control. The optical density of the TRPV6, CaBP-9k 
and GAPDH bands was quantified using ImageJ software. The values are presented as 
the ratio of TRPV6 and CaBP-9k optical density to the corresponding GAPDH optical 
density.  
 
Statistics 
The data sets of real-time and Western blot were tested for normality using the 
Kolmogorov-Smirnov Test [22]. Small deviations from normality were observed in 
the dataset of CaBP-9k mRNA expression in the placenta. Therefore, these data were 
analyzed by a nonparametric one-way analysis of variance using the Kruskal-Wallis 
test, followed by Dunn`s post test. The remaining datasets were analyzed using a 
parametric one way analyses of variance (ANOVA) followed by Dunnetts 
comparison test, where the second month was taken as the control group. Real-time 
and Western blot data sets of animals with retained fetal membranes in comparison to 
animals that discharged the fetal membranes were analyzed by an unpaired one-tailed 
t-test. For all of the statistical analyses, the software programme GraphPad Prism 5.0 
(GraphPad Software Inc., San Diego, CA, USA) was used. P<0.05 was considered 
statistically significant. Data are presented as means ± SD. 
 
Results 
 
Expression of TRPV6 and Calbindin-D9k mRNA in the uterus and placenta 
during pregnancy  
TRPV6 and CaBP-9k mRNA expression in the uterine wall and in the placentomes 
from the 2nd to 9th months of pregnancy was investigated by quantitative real-time 
(TaqMan) PCR. In the uterine wall, TRPV6 mRNA was detected throughout 
pregnancy with the highest levels in the 7th and 8th months (p<0.05) (Fig. 1A). 
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Placental TRPV6 expression levels increased from the 2nd month to the highest levels 
in the 7th, 8th and 9th months of pregnancy (p<0.05) (Fig. 1B). 
Interplacentomal uterine CaBP-9k mRNA expression was detected throughout 
pregnancy with a significant increase in the 7th and 8th months (p<0.05) (Fig. 1C).  
In the placentomes CaBP-9k mRNA was detected throughout the pregnancy without 
any significant changes (p>0.05) (Fig. 1D). 
 
Localisation of TRPV6 protein in the uterus and placenta during pregnancy 
Immunohistochemistry was performed to determine the localisation of TRPV6 in the 
uterine intercaruncular wall and in the placentomes during pregnancy (Fig. 2, 3). In 
the uterus TRPV6 protein was detected in the luminal and in the glandular epithelium 
and revealed the strongest labelling in the glandular epithelium in the 3rd month and 
from the 7th month until parturition (Fig. 2). 
In the placenta, TRPV6 was primarily expressed in the inner layer of the placentomes 
throughout pregnancy. Considerably lower staining was found in the middle and outer 
layers of the labyrinth (Fig.3 A, D). Strongest labelling was seen in the adherent fetal 
membranes (Fig. 3A, C). The distribution at the cellular level was diffuse (Fig. 3B).  
 
Localisation of CaBP-9k protein in the uterus and placenta during pregnancy 
The localisation of CaBP-9k in the uterine endometrium and in the placentomes was 
investigated by immunohistochemistry (Fig. 4, 5). In the endometrium, CaBP-9k was 
detected in the luminal and glandular epithelium. The strongest staining intensity was 
visible in the glandular epithelium of the 7th and 8th months of pregnancy (Fig. 4C, 
D). Furthermore the trophoblast epithelium of the adherent fetal membranes was 
strongly stained (Fig. 4A, B).  
Placental CaBP-9k protein was mainly detected in the luminal, inner layer and in the 
fetal membranes (Fig. 5A, C). Staining intensity decreased towards the outer labyrinth 
layer. On the cellular level, CaBP-9k was expressed in the cytoplasm and nuclei of 
the maternal crypt epithelium and in the uni- and binucleate fetal cells. The strongest 
staining was found in the binucleate cells and in the maternal crypt epithelium. In the 
latter the staining intensity increased towards parturition (Fig. 5B, D). 
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Western blot analyses of TRPV6 and CaBP-9k protein in the uterus and 
placenta during pregnancy 
In addition to the protein localisation, the expression of TRPV6 and CaBP-9k protein 
in the uterine wall and in the placentomes was further investigated by Western blot 
analyses (Fig. 6,7). In both the uterine and placental tissues, bands of TRPV6 with a 
molecular mass of 75kDa were detected from the 2nd to the 9th months without 
significant changes in expression levels (Fig. 6). In some animals a second band of 
approximately 90kDa was detected in the 2nd and/or 3rd months, which represents the 
glycosylated variation of TRPV6. 
Bands of CaBP-9k protein with a molecular weight of 9kDa were detected in the 
uterine and placental tissues (Fig. 7). The highest (p<0.05) expression levels were 
found in the uterine endometrium in the 7th month of pregnancy (Fig. 7B). In the 
placenta, no significant changes were detectable during pregnancy (Fig. 7D). 
 
Expression and localisation of TRPV6 and CaBP-9k in the placenta post 
partum in cows with and without retention of fetal membranes 
The placental mRNA levels of TRPV6 and CaBP-9k of animals that retained fetal 
membranes postpartum compared to animals that discharged fetal membranes were 
examined by real-time PCR. Neither the TRPV6 nor the CaBP-9k expression levels 
showed significant differences between the groups (p>0.5) (Fig. 8). 
Immunolabelling of TRPV6 and CaBP-9k protein was performed to localise these 
proteins in the placentomes of animals that retained and animals that discharged the 
fetal mambranes (Fig. 9, 10). The strongest labelling of both proteins was detected in 
the fetal membranes in both groups. In the placentome, TRPV6 was found in the 
maternal part of the placentome and in the trophoblast cells of both groups (Fig. 9B, 
D). Strong staining of TRPV6 was found in the maternal crypt epithelium of animals 
that retained their fetal membranes (Fig. 9D). Similar observations were made in the 
distribution of CaBP-9k in the placentome. Besides the strong staining in the fetal 
membranes (Fig. 10A, C), strongest signals were localised in the binucleate 
trophoblastic cells and in the maternal crypt epithelium of cows that retained fetal 
membranes (Fig. 10D). The uninucleate cells were also stained, but the intensity was 
considerably weaker. 
In the Western blot analyses, no significant differences in TRPV6 and CaBP-9k 
expression were detected between the groups (p>0.5) (Fig. 11). 
! "'!
Discussion 
 
The results of the current study show for the first time that TRPV6 is expressed in 
time- and cell type specific patterns during different stages of pregnancy in the uterine 
endometrium and placentomes in the cow, indicating a functional role for this protein 
in Ca2+ metabolism during pregnancy. Furthermore, the expression patterns of CaBP-
9k as an important intracellular Ca2+ transporter and buffer were investigated to check 
for possible colocalisation and functional correlation between both factors. 
In other species, such as rodents and pigs, TRPV6 seems to participate in the 
implantation process, in the maintenance of pregnancy, in the fetal Ca2+ supply and in 
fetal development [1, 2, 4, 11]. CaBP-9k may play a major role in the implantation 
process, in the regulation of myometrial activity and in the regulation of materno-fetal 
Ca2+ transport [12, 25, 26]. The expression of CaBP-9k in the bovine endometrium 
and placentomes has been described previously [16, 27], however, it has not been 
shown to correlate with TRPV6 expression nor with pathological conditions such as 
fetal membrane retention.  
In the current study, uterine expression of both TRPV6 and CaBP-9k mRNA was 
highest in the 7th and 8th months of pregnancy, the time of enhanced fetal growth and 
skeletal mineralization [7]. The localisation of both proteins in the glandular and 
luminal uterine epithelium indicates an increase in Ca2+ transport through or demand 
within these epithelia, which is met by high expression of TRPV6 and CaBP-9k.  
Ca2+ plays a key physiological role in many cellular processes, including in secretory 
and exocytotic processes [28], so the increased demand in the glandular and luminal 
epithelia may correlate with the secretory activity of the epithelial cells. The glandular 
and luminal epithelia are responsible, among other functions, for the production and 
secretion of histiotrophe, which is essential for fetal development [29] and growth. 
Thus, the localisation and the expression of TRPV6 and CaBP-9k in the uterine 
endometrium, mainly in the last trimester which is the time of enhanced fetal growth, 
indicate a functional role in secretory activities and therefore in fetal nourishment and 
development.  
This idea is further supported by the high expression of TRPV6 and CaBP-9k in the 
fetal membranes, indicating a high interplacentomally active Ca2+ transport into the 
fetus, which previously has been demonstrated in-vitro by Ussing-chamber studies in 
! "(!
sheep [30]. The colocalisation of both proteins suggests a functional correlation 
between TRPV6 and CaBP-9k in the bovine endometrium, which is well documented 
for other epithelia such as the small intestine [31].  
In the present study, the results of the Western blot analyses did not show any 
significant time-dependent changes in the expression of either of the proteins with the 
exception of uterine CaBP-9k. Moreover, distinct individual variations were detected 
between animals at the same stages of pregnancy, as evidenced by the high standard 
variations (SD) of the data obtained. The immunohistochemistry results illustrate that 
the measured protein (and mRNA) levels are very dependent on the anatomical 
composition of the samples taken for the Western blot analyses and that even small 
changes in anatomical structure and composition can be responsible for these 
variations. This could also be a reason for the divergence between the measured 
mRNA and protein levels, particularly since the results of the immunohistochemistry 
demonstrate increased protein expression in the 7th and 8th months. Nevertheless, the 
Western blot data show a clear trend of expression patterns and provide additional 
useful information. Furthermore, the antibody used for the TRPV6 Western blot 
analyses detected two proteins of approximately 75 and 90kDA. Since TRPV6 is a 
glycoprotein [32], analyses of glycosylation were performed. After incubation in the 
presence of N-glycosidase F, only the smaller variation of 75kDa was detectable, 
demonstrating that the 90kDa band represents the glycosylated variation of TRPV6. 
Inside the placentome, TRPV6 was mainly expressed in the luminal, inner layer of the 
labyrinth. While a gradual increase in placental TRPV6 mRNA was found towards 
parturition, the protein expression levels did not change significantly throughout 
pregnancy. A possible role for the discrepancy between mRNA and protein levels 
may be post-trancriptional regulation, or the above-mentioned possibility of small 
divergences in anatomical structure. A similar placental increase of TRPV6 mRNA 
was described in rats [2], while mouse placental TRPV6 expression peaks in the 
middle but not at the end of pregnancy [1]. The expression patterns of TRPV6 in the 
bovine placenta indicate an influence on placental Ca2+ metabolism, but their precise 
function remains unclear.  
The considerably higher expression of TRPV6 protein in the interplacentomal fetal 
membranes compared to its expression in the placentomes provides evidence that 
materno-fetal Ca2+ transport occurs mainly in the interplacentomal regions and 
TRPV6 seems to play a crucial role in this process in the cow. Similar results are 
! ")!
documented in mice, where the intra- and extra-placental yolk sac is described to be 
the site of materno-fetal Ca2+ transport in which TRPV6 seems to be a crucial element 
[4].  
The high expression of CaBP-9k and the colocalisation with TRPV6 in the fetal 
membranes supports this theory. It has been demonstrated in earlier studies that 
CaBP-9k levels in the ruminant interplacental trophoblasts are eight to ten times 
higher than in the placentomal region [27], which confirms our results and supports 
the idea of a facilitated diffusion of Ca2+ through the fetal membranes to supply the 
enhanced fetal need for Ca2+, especially in the last trimester of pregnancy. 
The intraplacetomal distribution of CaBP-9k, mainly at the luminal side of the 
labyrinth, correlates with TRPV6 localisation, but on the cellular level there are 
distinct variations. CaBP-9k is mostly expressed in the binucleate trophoblast cells 
(BNC), as described previously [16] and in the maternal crypt epithelium, while the 
distribution of TRPV6 is more diffuse. Interestingly, the staining intensity of CaBP-
9k in the maternal epithelium increases towards parturition. The distribution of CaBP-
9k and its changes indicate a functional role in placentomal Ca2+ metabolism. As 
described before, Ca2+ is important for many cell physiological processes, which are 
also crucial for placental development and degradation [6]. Thus, the high expression 
of CaBP-9k in the binucleate trophoblast cells may reflect the intracellular need for 
Ca2+ to support the active metabolism of these cells. In the ruminant placenta, the 
BNCs are, among other cells, responsible for the synthesis of hormones and proteins, 
for migration and cell-cell-interactions [33], all processes which are Ca2+ dependent 
[34, 35]. 
Furthermore, the high CaBP-9k expression in the maternal crypt epithelium possibly 
reflects the increased Ca2+ requirement for cell-specific processes, such as integrin-
mediated placentation, placental growth and placental maturation [22]. The important 
role of intracellular Ca2+ as a mediator of processes concerning placental maturation 
in the last trimester, such as degradation, apoptosis and separation, may explain the 
increase of CaBP-9k expression by the maternal epithelium in the last trimester of 
pregnancy. Based on this theory, it is possible that disturbed Ca2+ cell metabolism 
influences maturation of the placenta and apoptotic degradation of the maternal crypt 
epithelium, which could lead to a disturbance in release of the fetal membranes after 
parturition [19, 22]. Therefore, this study further examined the expression patterns of 
TRPV6 and CaBP-9k in animals that retained the fetal membranes compared to 
! "*!
animals that discharged the fetal membranes within 12 hours after parturition. In the 
placentomes, both proteins were mainly detected in the maternal epithelium, CaBP-9k 
additionally in the trophoblast cells, especially in the binucleate cells. This 
localisation explains the higher expression in animals that retained the fetal 
membranes, since the maternal epithelium is largely intact in theses animals while it 
is strongly reduced in cows with normal fetal membrane release. Thus, the idea that a 
deficiency of TRPV6 or CaBP-9k expression leads to a disturbance in release of fetal 
membranes could not be confirmed. Expression of both proteins reflects the status of 
the epithelia involvement and is rather a consequence than the cause of the retention 
of fetal membranes. 
 
Conclusion 
 
The results of the present study demonstrate for the first time that TRPV6 is 
dynamically expressed in the bovine uterine endometrium and in the placentomes 
during pregnancy, indicating a functional role in Ca2+ metabolism during gestation. 
The expression of TRPV6 and CaBP-9k in the uterine glandular epithelium, in the 
placental maternal epithelium and the fetal chorionic membranes suggests that these 
proteins are involved in materno-fetal Ca2+ transfer mainly through interplacental 
transport, especially in the last trimester of pregnancy, a time of enhanced fetal 
growth. Their distinct expression in the uterine glandular epithelium indicates that 
TRPV6 and CaBP-9k participate in uterine secretory processes, which are crucial for 
fetal nourishment and development.  
Due to their increased expression in the maternal epithelium and in the binucleate 
trophoblastic cells in the placentomes, TRPV6 and CaBP-9k may function as 
important elements in controlling placental development, maturation and degradation 
through the regulation of intracellular Ca2+ metabolism. However, neither TRPV6 nor 
CaBP-9k seem to be causative in the retention of fetal membranes. 
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Figures 
 
Figure 1 – Uterine and placentomal TRPV6 and CaBP-9k mRNA expression  
TRPV6 and CaBP-9k mRNA expression in the intercaruncular wall (Fig. 1A, C) and 
in the placenta (n!3 animals/month) (Fig. 1B, D) from the 2nd to 9th months of 
pregnancy, determined by real-time PCR. Bars with ** differ significantly (p<0.05) 
compared to the second month (*). Data were analysed using a parametric one-way 
analysis of variance (ANOVA), followed by Dunnett’s comparison test and are 
! #$!
presented as means ± SD. The nonparametric dataset of placental CaBP-9k was 
analysed using the Kruskal-Wallis test, followed by Dunn`s post test. 
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Figure 2 – Immunolabelling of TRPV6 in the uterine endometrium  
Localisation of uterine TRPV6 during pregnancy with strong labelling in the 
glandular (GE) and luminal epithelia (LE). Fig. 2F shows a negative control, without 
anti-TRPV6 treatment. Scale bars indicate 200µm. 
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Figure 3 – Immunolabelling of TRPV6 in the placentomes and adherent fetal 
membranes  
Localisation of TRPV6 during pregnancy in the placenta and adherent membranes 
with strong staining in the inner layer (IL) of the placentome  (A, D) and the adherent 
fetal membranes (FM) (A, C). Considerably weaker staining in the middle (ML) and 
outer labyrinth (OL) layers (A, B). Scale bars indicate 200µm. 
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Figure 4 – Immunolabelling of CaBP-9k protein in the uterine endometrium  
Localisation of CaBP-9k in the glandular (GE) and luminal epithelia (LE) during 
pregnancy (A-D). Strongest staining was detected in the fetal membranes (FM) (A, 
B). Scale bars indicate 200µm. 
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Figure 5 - Immunolabelling of CaBP-9k in placentomes and adherent fetal 
membranes  
Localisation of CaBP-9k during pregnancy with strong signals in the inner layer (IL) 
of the placentome and in the fetal membranes (FM) compared to the outer labyrinth 
layer (OL) (A, C). Strong staining in the binucleate trophoblast cells (BNC) and in the 
maternal epithelium (ME) inside the placentome (B, C). Fig. 2F shows a negative 
control, without anti-TRPV6 treatment. Scale bars indicate 200µm. 
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Figure 6 – Western blot analyses of endometrial and placentomal TRPV6 
protein during pregnancy  
A) Representative Western blot of TRPV6 protein expression in the uterine wall (n=3 
animals/month). Bands of approximately 75 kDa were detected. An additional band of 
approximately 90 kDa was seen in the 2nd and 3rd months. After incubation with N-
glycosidase F (PNGase F), only the smaller band of 75kDa was seen, demonstrating 
that the other band is the glycosylated variant of TRPV6. As a negative control, 
samples were preincubated with a control antigen.  
! #'!
B) Relative expression of TRPV6 to GAPDH was determined by densitometry using 
ImageJ software. No significant changes were detected (p>0.05).  
C) Representative Western blot analyses of TRPV6 in the placenta from 2nd to 9th 
months of pregnancy (n=3 animals/month).  
D) The expression of TRPV6 relative to GAPDH was determined by measuring the 
optical density using ImageJ software. No significant changes (p>0.05) were detected. 
Data were analysed using a parametric one-way analysis of variance (ANOVA), 
followed by Dunnett’s comparison test, where the second month was taken as the 
control group, and are presented as means ± SD. 
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Figure 7 - Western blot analyses of endometrial and placental CaBP-9k protein 
during pregnancy 
A) Representative Western blot of CaBP-9k in the uterine wall (n=3 animals/month). 
Bands of approximately 9 kDa were detected.  
B) The highest expression relative to GAPDH was found in the 7th month of 
pregnancy, determined by measuring the optical density using ImageJ software. Bars 
with ** differ significantly (p<0.05) compared to the 2nd month (*). 
C) Representative Western blot of CaBP-9k in the placenta (n=3 animals/month).  
D) Relative expression levels of CaBP-9k to GAPDH were determined by 
densitometry using ImageJ software. Significant changes in the expression levels 
were not detected (p>0.05). 
! #(!
Data were analysed using a parametric one-way analysis of variance (ANOVA), 
followed by Dunnett’s comparison test, where the second month was taken as the 
control group, and are presented as means ± SD. 
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Figure 8 - Placental TRPV6 and CaBP-9k mRNA expression post partum in 
cows with and without retained fetal membranes 
Detection of TRPV6 (A) and Calbindin-D9k (CaBP-9k) (B) mRNA levels in the 
placenta of postpartum cows that retained the fetal membranes for more than 12 hours 
(RFM; n=5) and cows that discharged the fetal membranes (DFM; n=6), measured by 
real-time PCR (TaqMan). No significant changes were observed (p>0.05). Data were 
analyzed by an unpaired one-tailed t-test and are presented as means ± SD. 
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Figure 9 – Localisation of TRPV6 protein in the placentomes and fetal 
membranes in cows with (RFM) (C, D) and without retained fetal membranes 
(DFM) (A, B) 
Strongest labeling of TRPV6 protein was seen in the fetal membranes (FM) of all 
animals and in the maternal crypt epithelium (ME) of cows with RFM (D). 
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Figure 10 - Localisation of placental CaBP-9k protein post partum in cows with 
(RFM) (C, D) and without retained fetal membranes (DFM) (A, B) 
Strong staining was detected in the fetal membranes (FM) of all investigated animals 
and in the maternal crypt epithelium (ME) of animals with retained fetal membranes 
(D) and in the binucleate trophoblast cells (BNC) of all animals. 
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Figure 11 – Western blot analyses of placental TRPV6 and CaBP-9k 
postpartumin cows with (RFM) and without retained fetal membranes (DFM) 
A) Representative Western blot of TRPV6 in the placenta. Bands of approximately 75 
kDa were detected in all animals.  
B) Relative expression of TRPV6 was determined by measuring the optical density 
relative to GAPDH using ImageJ software. Significant changes in expression levels 
were not detected (p>0.05). 
C) Representative Western blot of CaBP-9k. 
D) The relative expression levels to GAPDH were determined by densitometry using 
ImageJ software. No significant changes were detected (p>0.05). 
Data were analyzed by an unpaired one-tailed t-test and are presented as means ± SD. 
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Tables 
 
Table 1 – Sequences of primers and probes  
 
Primer Primer Sequence Accession " 
TRPV6 forward 
TRPV6 reverse 
TRPV6 probe 
 
5#-CAAGGAGCCCATGACATCTGA-3# 
5#-CAGGGCTTTCACGAGGTTCA-3# 
5#-CGGCCCTGCACATAGCAGTCATGAA-3# 
 
NM_001206189.1 
CaBP-9k forward 
CaBP-9k reverse 
CaBP-9k probe 
 
5#-TCTCCAGAAGAACTGAAGGGC -3# 
5#-CCAACACCTGGAATTCTTCG-3# 
5#-TCCAAGCACCCTCGATGAGCTTTTTGA-3# 
 
NM_174257.2 
GAPDH forward 
GAPDH reverse 
GAPDH probe 
 
5#-GCGATACTCACTCTTCTACCTTCGA-3# 
5#-TCGTACCAGGAAATGAGC TTGAC-3# 
5#-CTGGCATTGCCCTCAACGACCACTT-3# 
 
 
NM_001034034.1 
 !
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